Picture of Indaptus Therapeutics logo

INDP — Indaptus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Intec Pharma Q3 Loss Per Share $0.95

Nov 5 (Reuters) - Intec Pharma Ltd  NTEC.O :
    * INTEC PHARMA REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
AND
PROVIDES CORPORATE UPDATE
    * Q3 LOSS PER SHARE $0.95
    * Q3 EARNINGS PER SHARE ESTIMATE $-0.05 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nPn17G29Za 
Further company coverage:  NTEC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Indaptus Therapeutics

See all news